| 99mTc-MAAΔ | Resin spheres♣ | Glass spheres♠|
---|---|---|---|
Commercial name |  | SIR-Spheres® | TheraSphere® |
Manufacturer | Â | Sirtex Medical | Boston Scientific |
Diameter (μm) ± standard deviation (μm) | 31.2; Range (10–100) non spherical | 32.5 ± 2.5; range (20–60) | 25 ± 5 |
Specific gravity | n/a | 1.6 g/mL | 3.6 g/mL |
Vial activity (GBq) | 1.5 (α)–3.7 (β) | 2.5–10** | From 3* to 20*, with 0.5 step |
Activity per particle (Bq) | 333 (α)–822 (β) | 42–166** | 4354*, 1539♦, 544♥ |
Millions of particle per GBq | 3 (α)–1.2 (β) | 24–6** | 0.23*, 0.65♦, 1.84♥ |
Millions of particles in a typical administration | 0.3–0.7 | 1.2 GBq 28.8–7.2** millions | 2.6 GBq 1.7♦ 4.8♥ millions |
Stasis phenomenon (backflow, jammed injection) | Never reported | Reported | Never reported |
Material | Human albumin | Resin with 90Y on surface | 90Y in glass matrix |
Shelf life | 6 h from labelling | (− 4, + 1) days | 12 days |
Handling vial for dispensing | Required | Required | Not required |
Vial fractionation in syringe | Required | Required | Not required |
Iodinated contrast medium during administration | Not required | Recommended | Not required |